Myriad Genetics Stock (MYGN)
Track Myriad Genetics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
MYGN
Myriad Genetics
healthcare
$4.17
▼ -0.22 (-5.30%) past year
Market Cap
$363.63M
P/E Ratio
—
1Y Return
-5.30%
EPS (TTM)
-$4.32
Read the latest TheStreet Pro articles mentioning Myriad Genetics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning MYGN yet.
Daily Diary Mentions
0 mentionsNo diary mentions for MYGN yet.